Cost-effectiveness of extending medicare coverage of immunosuppressive medications to the life of a kidney transplant

American Journal of Transplantation

Volumn 4, Issue 10, 2004, Pages 1703-1708

  Yen, Eugene F ^a   Hardinger, Karen ^b   Brennan, Daniel C ^a   Woodward, Robert S ^d   Desai, Niraj M ^a   Crippin, Jeffrey S ^a   Gage, Brian F ^a   Schnitzler, Mark A ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

Immunosuppression; Kidney transplantation; Medicare; Public policy; Renal failure

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

AGE; ARTICLE; CALCULATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DATA BASE; DISABILITY; GRAFT SURVIVAL; HEALTH CARE POLICY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICARE; MONEY; POLICY; PRIORITY JOURNAL; PROBABILITY; SURVIVAL TIME; UNITED STATES;

COST-BENEFIT ANALYSIS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MARKOV CHAINS; MEDICARE; SURVIVAL; TIME FACTORS;

EID: 4744337520     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00565.x     Document Type: Article

References (25)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-30.
2. Schnitzler MA, Whiting JF, Brennan DC et al. The Expanded Criteria Donor Dilemma in Cadaveric Renal Transplantation. Transplantation Forthcoming 2003.
3. Smith CM, Webb R, Naperala S, Pugh A, Tolleris CB. The U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients. Transplant Data 1991-2000 Transplant Program Specific Reports on the World Wide Web. 20001. Washington, DC: Department of Health and Human Services, Health Resource and Services Administration, 2001 Annual Report.
4. Rovelli M, Palmeri D. Bossier E, Bartus S, Hull D, Schweitzer R. Noncompliance in organ transplant recipients. Transplant Proc 1989; 21: 833-4.
5. Gaston RS, Hudson SL, Ward M, Jones P, Macon R. Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc 1999; 31: 21S-23S.
6. Hong JH, Sumrani N, Delaney V, Dibenedetto A, Butt KM. Cases of late renal allograft failure in the ciclosporin era. Nephron 1992; 62: 272-279.
7. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374-377.
8. Dobson A, DaVanzo J, Kerns J, Appendix E. Cost estimates for expanded medicare benefits: skin cancer screening. Medically necessary dental services, and immunosuppressive therapy for transplant recipients. In: Field MJ, Lawrence RL, Zwanziger L (eds). Extending Medicare Coverage for Preventive and Other Services. Institute of Medicine. Washington, D.C.: National Academy Press, 2000: 347-362.
9. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL, Brennan DC. Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants. Am J Transplantation 2001; 1: 69-73.
10. Renal US Data System. Researchers Guide to the USRDS Database 2002. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.
11. Hornberger JC, Best JH, Garrison LP. Cost-effectiveness of repeat medical procedures: kidney transplantation as an example. Med Decis Making 1997; 17: 363-372.
12. Whiting JF. For the Transplant Outcomes Research Standards for economic and quality of life studies in transplantation. Transplantation 2000; 70: 1115-1121.
13. Consumer Price Index 2002. Washington, D.C.: U.S. Bureau of Labor Statistics, 2002.
14. Gold ME, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996: 309.
15. Rovelli M, Palmeri D, Bossier E, Bartus S, Hull D, Schweitzer R. Noncompliance in organ transplant recipients. Transplant Proc 1989; 21: 833-834.
16. Sanders CE, Curtis JJ, Julian BA et al. Tapering or discontinuing cyclosporine for financial reasons - a single-center experience. Am J Kidney Dis 1993; 21: 9-15.
17. De Geest S, Borgermans L, Gemoets H et al. Incidence, determinants and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340-347.
18. Didlake RH, Dreyfus K, Kerman RH, VanBuren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988; 20: 63-69.
19. Chisholm MA. Issues of adherence to immunosuppressant therapy after solid-organ transplantation. Drugs 2002; 62: 567-575.
20. Kory L. Non-adherence to immunosuppressive medication: a pilot survey of members of the transplant recipients international organization. Transplant Proc 1999; 31: 14-15S.
21. Kennedy J, Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health 2002; 92: 1120-1124.
22. Paris W, Dunham S, Sebastian A, Jacobs C, Nour B. Medication nonadherence and its relation to financial restriction. J Transpl Coord 1999; 9: 149-152.
23. Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparitive analysis. Am J Kidney Dis 1991; 18: 62-70.
24. Paris W, Woodbury A, Thompson S et al. Social rehabilitation and return to work after cardiac transplantation - a multicenter survey. Transplantation 1992; 53: 433-438.
25. Markell MS, DiBenedetto A, Maursky V et al. Unemployment in Inner City Renal Transplant Recipients: Predictive and Sociodemographic factors. Am J Kidney Dis 1997; 29: 881-887.